UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| | | |
| Date of Report (Date of Earliest Event Reported): | | April 12, 2005 |
TLC Vision Corporation
__________________________________________
(Exact name of registrant as specified in its charter)
| | | |
| New Brunswick | 0-29302 | 980151150 |
_____________________
(State or other jurisdiction | _____________
(Commission | ______________
(I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| | | |
| 5280 Solar Drive, Suite 100, Mississauga, Ontario | | L4W 5M8 |
_________________________________
(Address of principal executive offices) | | ___________
(Zip Code) |
| | | |
| Registrant’s telephone number, including area code: | | (905) 602-2020 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On April 12, 2005 the Company issued a press release announcing that Jim Wachtman, President and CEO, and Steve Rasche, VP Finance and CFO, will review TLCVision's performance and growth strategy at Scotia Capital Pharmaceutical and Biotechnology Conference at Scotia Plaza in Toronto, on Tuesday April 26, 2005, 2:00 p.m. EST. The presentation will be webcast live and can be accessed under the "Webcasts" link in the Investor Relations section at www.tlcv.com. A copy of the Press Release is attached hereto as an exhibit.
Item 9.01. Financial Statements and Exhibits.
Press Release dated April 12, 2005, Announcing Presentation by the Company at Scotia Capital Pharmaceutical and Biotechnology Conference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | TLC Vision Corporation |
| | | | | |
| April 14, 2005 | | By: | | /s/ Brian Andrew
|
| | | | |
|
| | | | | Name: Brian Andrew |
| | | | | Title: General Counsel |
Exhibit Index
| | | |
| Exhibit No. | | Description |
| |
|
99.1 | | April 12, 2005 Press Release |
